ENO1 and neoplasm: Tumor cell-derived CM, as well as atypical tumor suppressors such as extracellular Eno1 and Ubc, preferentially inhibited the viability of tumor cells over non-tumor cells, and they downregulated programmed death-ligand1 (PD-L1), one of the targets of immunotherapy 10.